Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1146A Nasal Spray for Common Cold
NCT03005067Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2016
- Primary completion
- Jun 2017
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of carbomer in common cold, sponsored by GSK. Started Dec 2016; status: completed.
02
Drugs
carbomer
03
Conditions
common cold
Beyond the preview
Go deeper on NCT03005067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005067.